Key stats
About iShares Genomics Immunology and Healthcare Index ETF Trust Units
Home page
Inception date
Apr 26, 2022
Structure
Canadian Mutual Fund Trust (ON)
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Primary advisor
BlackRock Asset Management Canada Ltd.
ISIN
CA46437W1059
The fund holds a concentrated portfolio of global companies in the biopharmaceutical and healthcare equipment and services industries that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering. In addition to these industry screens, companies must also meet certain size and liquidity measures for index eligibility. The underlying index then assigns a Relationship Keyword Score to each of the eligible companies using the FactSet Supply Chain Relationships database in search for keywords related to Genomics and Immuno Biopharmaceutical products and technologies. The top 50 names with the highest scores are included in the index. Holdings are weighted by market-cap and are constrained such that no individual security exceeds 4% weight of the portfolio. The index rebalances semi-annually.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.89%
Health Technology98.98%
Health Services0.91%
Bonds, Cash & Other0.11%
Cash0.11%
Stock breakdown by region
North America61.77%
Europe31.80%
Asia6.43%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
XDNA invests in stocks. The fund's major sectors are Health Technology, with 98.98% stocks, and Health Services, with 0.91% of the basket. The assets are mostly located in the North America region.
XDNA top holdings are BeOne Medicines Ltd. and Incyte Corporation, occupying 5.05% and 4.84% of the portfolio correspondingly.
XDNA last dividends amounted to 0.16 CAD. Six months before that, the issuer paid 0.01 CAD in dividends, which shows a 92.38% increase.
XDNA assets under management is 4.91 M CAD. It's risen 9.17% over the last month.
XDNA fund flows account for 0.00 CAD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, XDNA pays dividends to its holders with the dividend yield of 0.53%. The last dividend (Jun 30, 2025) amounted to 0.16 CAD. The dividends are paid semi-annually.
XDNA shares are issued by BlackRock, Inc. under the brand iShares. The ETF was launched on Apr 26, 2022, and its management style is Passive.
XDNA expense ratio is 0.47% meaning you'd have to pay 0.47% of your investment to help manage the fund.
XDNA follows the NYSE FactSet Global Genomics and Immuno Biopharma Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
XDNA invests in stocks.
XDNA price has risen by 6.74% over the last month, and its yearly performance shows a −6.62% decrease. See more dynamics on XDNA price chart.
NAV returns, another gauge of an ETF dynamics, showed a 8.87% increase in three-month performance and has decreased by −1.87% in a year.
NAV returns, another gauge of an ETF dynamics, showed a 8.87% increase in three-month performance and has decreased by −1.87% in a year.
XDNA trades at a premium (0.09%) meaning the ETF is trading at a higher price than the calculated NAV.